AIM ImmunoTech Inc. Income Statement
AIM|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
AIM ImmunoTech Inc. reported $88,000 in revenue and $14M in net loss for FY2025. Revenue has declined at a 1.6% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.0K | $202.0K | $141.0K | $135.0K | $163.0K | $163.0K | $140.0K | $367.0K | $133.0K | $92.0K | $133.0K | $197.0K | $150.0K | $213.0K | $111.0K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | $1.3M | $1.2M | $2.0M | $584.0K |
| SG&A Expense | $7.7M | $21.1M | $13.1M | $8.7M | $8.7M | $8.7M | $7.0M | $6.2M | $7.1M | $7.7M | $7.1M | $9.1M | $7.7M | $9.1M | $5.8M |
| R&D Expense | $3.9M | $10.9M | $7.0M | $7.7M | $5.7M | $5.7M | $4.7M | $4.8M | $8.0M | $5.1M | $8.0M | $9.0M | $8.4M | $9.5M | $7.0M |
| Operating Income | -$11.7M | -$31.9M | -$19.9M | -$18.8M | -$15.2M | -$15.2M | -$12.4M | -$11.5M | -$16.6M | -$13.8M | -$16.6M | -$19.1M | -$17.2M | -$20.3M | -$13.3M |
| Interest Expense | $812.0K | $585.0K | - | $67.0K | $672.0K | $672.0K | $427.0K | $201.0K | - | - | $3.0K | $11.0K | $16.0K | $24.0K | $0 |
| Net Income | -$14.0M | -$29.0M | -$19.4M | -$19.1M | -$14.4M | -$14.4M | -$9.4M | -$9.8M | -$15.2M | -$7.5M | -$15.2M | -$17.4M | -$16.2M | -$17.4M | -$7.2M |
| EPS (Basic) | -$30.92 | -$0.60 | -$0.40 | -$0.40 | - | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$30.92 | -$0.60 | -$0.40 | - | -$0.45 | -$2.58 | -$9.77 | -$0.29 | -$0.77 | -$1.11 | -$0.10 | -$0.12 | -$0.07 | -$0.10 | -$0.07 |
| Shares Outstanding | 655.3K | 49.1M | 48.1M | 48.0M | 42.2M | 10.4M | 1.1M | 32.9M | 24.2M | 20.6M | 204.0M | 168.7M | 166.5M | 135.6M | 135.2M |
| Operating Margin | -13254.6% | -15800.0% | -14129.8% | -13954.1% | -9295.7% | -9295.7% | -8887.9% | -3132.4% | -12518.8% | -15004.3% | -12518.8% | -9694.9% | -11444.7% | -9549.3% | -11949.6% |
| Profit Margin | -15861.4% | -14337.6% | -13790.8% | -14168.1% | -8834.4% | -8834.4% | -6717.1% | -2677.7% | -11451.1% | -8154.3% | -11451.1% | -8857.9% | -10816.7% | -8147.4% | -6468.5% |